This bill proposes significant updates to current statutes regarding gender transition procedures for minors. Under the new law, physicians or other health professionals would be prohibited from providing or referring any gender transition procedures to individuals under 18 years of age. Additionally, any health professional who violates this prohibition would be committing unprofessional conduct, subject to disciplinary action by their licensing entity. The bill also introduces provisions allowing individuals to assert claims for violations, seek compensatory damages, and outlines the process for bringing such claims, including the ability for minors to act through a parent or guardian. Furthermore, the bill defines key terms related to gender transition procedures, including "cross-sex hormones," "puberty-blocking drugs," and "gender transition procedure." It clarifies that certain medical services, such as those for individuals with disorders of sexual development or those necessary to treat complications from prior procedures, are exempt from these prohibitions. The effective date of the act is set for April 1, 2027, allowing time for current users of puberty-blocking drugs or cross-sex hormones to taper off their medications under medical supervision.

Statutes affected:
Introduced Version: 32-3230
Senate Engrossed Version: 32-3230